IDStewardship

JUNE 19, 2025

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. The piece advocates for therapeutic drug monitoring (TDM) in specific high-risk groups to personalize treatment.

HIV Treatment and Prevention Agents 130

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 130

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

HIV Treatment and Prevention Agents 73

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA 73

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face. The scope of the problem.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Pharmaceutical Companies Pharmaceutical Companies Vaccines 59

ISPE

JULY 6, 2023

billion US in 2022 for the global market share for prescription drugs produced using CM. 1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Table 1: List of FDA-approved commercial products using CM elements.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Friday Pearls

MARCH 4, 2022

18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunization 40

The Thyroid Pharmacist

JULY 20, 2023

And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. 42] In a smaller 2022 study, 13 non-professional female athletes were evaluated for iron deficiency. Patients on hemodialysis may be prescribed IV or subcutaneous ESAs during dialysis treatments.

Health and Personal Care Stores 98

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization 98

pharmaphorum

JANUARY 5, 2022

billion doses administered globally by 4th January, with 25 different vaccines either approved for use or under emergency use authorisation , 2022 starts on a more sombre note due to the rise of the Omicron variant. The next phase of the Covid-19 – from vaccines to treatments. Despite an estimated 9.25

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Vaccines FDA 98